1720 related articles for article (PubMed ID: 17039445)
1. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
[TBL] [Abstract][Full Text] [Related]
2. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges.
Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R
Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450
[TBL] [Abstract][Full Text] [Related]
4. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine.
Larson LJ; Schultz RD
Vet Ther; 2007; 8(4):305-10. PubMed ID: 18183549
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
Litster A; Nichols J; Volpe A
Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
[TBL] [Abstract][Full Text] [Related]
6. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus.
Spibey N; Greenwood NM; Sutton D; Chalmers WS; Tarpey I
Vet Microbiol; 2008 Apr; 128(1-2):48-55. PubMed ID: 18006253
[TBL] [Abstract][Full Text] [Related]
7. Protection of dogs against canine distemper by vaccination with a canarypox virus recombinant expressing canine distemper virus fusion and hemagglutinin glycoproteins.
Pardo MC; Bauman JE; Mackowiak M
Am J Vet Res; 1997 Aug; 58(8):833-6. PubMed ID: 9256965
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to parvovirus, distemper virus and adenovirus conferred to household dogs using commercial combination vaccines containing Leptospira bacterin.
Taguchi M; Namikawa K; Maruo T; Lynch J; Sahara H
Vet Rec; 2010 Dec; 167(24):931-4. PubMed ID: 21262693
[TBL] [Abstract][Full Text] [Related]
9. Clinical and serological response of wild dogs (Lycaon pictus) to vaccination against canine distemper, canine parvovirus infection and rabies.
van Heerden J; Bingham J; van Vuuren M; Burroughs RE; Stylianides E
J S Afr Vet Assoc; 2002 Mar; 73(1):8-12. PubMed ID: 12088076
[TBL] [Abstract][Full Text] [Related]
10. Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines.
Bergman JG; Muniz M; Sutton D; Fensome R; Ling F; Paul G
Vet Rec; 2006 Nov; 159(22):733-6. PubMed ID: 17127756
[TBL] [Abstract][Full Text] [Related]
11. Assessment of serum antibody titers against canine distemper virus, canine adenovirus type II, and canine parvovirus in Alaskan sled dogs before and after a long-distance race.
Banse HE; McKenzie EC; Nelson S; Hinchcliff KW
J Am Vet Med Assoc; 2008 Jun; 232(11):1669-73. PubMed ID: 18518808
[TBL] [Abstract][Full Text] [Related]
12. Thoughts on vaccination protocols.
Petzel B
J Am Vet Med Assoc; 2000 Nov; 217(10):1459. PubMed ID: 11128531
[No Abstract] [Full Text] [Related]
13. Thoughts on vaccination protocols.
McLaughlin MA
J Am Vet Med Assoc; 2000 Nov; 217(10):1458-9. PubMed ID: 11128530
[No Abstract] [Full Text] [Related]
14. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
McCaw DL; Thompson M; Tate D; Bonderer A; Chen YJ
J Am Vet Med Assoc; 1998 Jul; 213(1):72-5. PubMed ID: 9656027
[TBL] [Abstract][Full Text] [Related]
15. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
[TBL] [Abstract][Full Text] [Related]
16. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
Larson LJ; Schultz RD
Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
[TBL] [Abstract][Full Text] [Related]
17. Vaccination at different anatomic sites induces different levels of the immune responses.
Jin H; Xu Y; Shi F; Hu S
Res Vet Sci; 2019 Feb; 122():50-55. PubMed ID: 30453180
[TBL] [Abstract][Full Text] [Related]
18. Duration of serological response to canine parvovirus-type 2, canine distemper virus, canine adenovirus type 1 and canine parainfluenza virus in client-owned dogs in Australia.
Mitchell SA; Zwijnenberg RJ; Huang J; Hodge A; Day MJ
Aust Vet J; 2012 Dec; 90(12):468-73. PubMed ID: 23186088
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the humoral immune response induced by vaccination for canine distemper and parvovirus: a pilot study.
Vila Nova B; Cunha E; Sepúlveda N; Oliveira M; São Braz B; Tavares L; Almeida V; Gil S
BMC Vet Res; 2018 Nov; 14(1):348. PubMed ID: 30445957
[TBL] [Abstract][Full Text] [Related]
20. Serum antibody response to canine parvovirus, canine adenovirus-1, and canine distemper virus in dogs with known status of immunization: study of dogs in Sweden.
Olson P; Klingeborn B; Hedhammar A
Am J Vet Res; 1988 Sep; 49(9):1460-6. PubMed ID: 3223653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
